Evidence map›Paper›PMID 40720770›Full record

ReviewFEMS microbiology reviews2025

Advances in Helicobacter pylori lipopolysaccharide structure and function.

Xiaoqiong Tang, Alfred Tay, Mohammed Benghezal, Barry J Marshall, Hong Tang, Hong Li

Abstract readReview
In one paragraph

Review in FEMS microbiology reviews, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Microbiology and molecular biology reviews : MMBR · 2026
    Review
  2. Article
  3. Virulence regulation in the fish pathogenFrontiers in cellular and infection microbiology · 2026
    Review
  4. Article
  5. BeyondMedicina (Kaunas, Lithuania) · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Xiaoqiong TangCenter of Infectious Diseases, West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, China.
Alfred TayHelicobacter pylori Research Laboratory, School of Biomedical Sciences, Marshall Centre for Infectious Disease Research and Training, University of Western Australia, Perth, Nedlands, 6009, Australia.
Mohammed BenghezalCenter of Infectious Diseases, West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, China.
Barry J MarshallHelicobacter pylori Research Laboratory, School of Biomedical Sciences, Marshall Centre for Infectious Disease Research and Training, University of Western Australia, Perth, Nedlands, 6009, Australia.
Hong TangCenter of Infectious Diseases, West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, China.
Hong LiCenter of Infectious Diseases, West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, China.ORCID 0009-0006-3391-4679

Funding

National Natural Science Foundation of China 32470189National Natural Science Foundation of China 82300649Natural Science Foundation of Sichuan Province 2024NSFSC1754West China Hospital, Sichuan University 139220012
6 · The paper itself

Abstract

Helicobacter pylori is a widespread pathogen responsible for chronic gastritis, peptic ulcers, and an elevated risk of gastric cancer. Lipopolysaccharide (LPS), localized exclusively in the outer leaflet of the outer membrane, is essential for maintaining bacterial integrity. Recent advances have deepened our understanding of H. pylori LPS structure, particularly lipid A modifications and the redefinition of the core oligosaccharide and O-antigen regions. The complete set of enzymes involved in LPS biosynthesis has been identified in the reference strain G27, and comparative genomics has revealed a notable regional difference (the absence of the heptan domain in East Asian strains). Here, we summarize recent insights into the structure and function of H. pylori LPS, emphasizing its role in bacterial persistence and its promise as a target for LPS-based glycoconjugate vaccine development.

Indexed as

Helicobacter pyloriLipopolysaccharidesHelicobacter InfectionsHumanslipopolysaccharide, Helicobacter pyloriLipopolysaccharidesADP-heptosecolonizationglycosyltransferaseHelicobacter pylorilipopolysaccharidevaccine

Identifiers

PMID40720770
PMCPMC12342981

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.